¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѸðüžÆÀÇÇÐȸ Á¦30Â÷ Çмú´ëȸ : 2024-06-15

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѸðüžÆÀÇÇÐȸ Á¦30Â÷ Çмú´ëȸ : 2024-06-15
±³À°ÀÏÀÚ : 2024-06-15
±³À°Àå¼Ò : Á¦ÁÖ ¸ÞÁ¾±Û·¡µåÈ£ÅÚ ÄÁº¥¼ÇȦ

±³À°ÁÖÁ¦ : ´ëÇѸðüžÆÀÇÇÐȸ Á¦30Â÷ Çмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑ»êºÎÀΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѸðüžÆÀÇÇÐȸ

´ã´çÀÚ : ¹Ú¼±È­
¿¬¶ôó : 02-2650-5274

À̸ÞÀÏ : office@ksmfm.or.kr

±³À°Á¾·ù : »êºÎÀΰú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : Á¦ÁÖƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 110,000¿ø  

ºñ°í Àü¹®ÀÇ(ȸ¿ø10¸¸¿ø/ºñȸ¿ø11¸¸¿ø)Àü°øÀÇ(6¸¸¿ø)°£È£»ç/±âŸ(3¸¸¿ø)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 08:00~08:25 µî·Ï ( )

±âŸ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 08:25~08:30 °³È¸»ç ( )

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 08:30~08:45 ºÐ¸¸ ½Ã°£°ú ÁøÅë °­µµ¸¦ ÁÙÀ̱â À§ÇÑ »ê¸ð ÀڱüöÃà ¹ÙÅÁÀÇ VR ½Ã½ºÅÛ È¿´É Æò°¡ Á¶±ÝÁØ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 08:45~09:00 ¹Ì¼¼¸ÕÁö ±âÀÎ Á¶»ê ¿¹Ãø Èļº À¯ÀüÀÚ ¹ß±¼À» À§ÇÑ Á¦´ëÇ÷ ¸ÞÆ¿È­ ºÐ¼® ¿¬±¸ ¹Ú¼±È­(ÀÌÈ­ÀÇ´ë)

±âŸ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 09:00~09:15 Æ丵Çмú»ó ½Ã»ó ¹× ³í¹®¹ßÇ¥ ( )

±âŸ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 09:15~09:30 ¸ðüÅÂ¾Æ ÀþÀº ÀÇÇÐÀÚ»ó ½Ã»ó ¹× ³í¹®¹ßÇ¥ ( )

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 09:30~09:40 (±¸¿¬) ÀӽŠÁß °íÇ÷¾Ð ÁúȯÀÇ À¯ÀüÀû ¼ÒÀΰú »ýÈ°½À°üÀÌ Àå±âÀû ½ÉÇ÷°ü À§Çèµµ¿¡ ¹ÌÄ¡´Â ¿µÇâ ±èÁöȸ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 09:40~09:50 (±¸¿¬) Exploring the applicability of Methacrylate Carboxymethyl Chitosan for the fetal treatment of gastroschisis À§Á¤ÇÏ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 09:50~10:00 (±¸¿¬) Clinical significance of ¡®Dual Positivity¡¯ for neural tube defect and Down syndrome on maternal serum screening ÇÔ¼öÁö(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 10:00~10:10 (±¸¿¬) Shotgun metagenomics of vaginal microbiome in cervical shortening: Implications for preterm birth risk ¼Õ°¡Çö(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 10:10~10:20 (±¸¿¬) Adverse Obstetric Outcomes Associated with Protocol of Embryo Transfer È«À¯¹Ì(Â÷ÀÇ°úÇдë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 10:20~10:30 (±¸¿¬) Isolation of circulating fetal cells using immuno-affinity & microfluidic method for non-invasive prenatal diagnostic test Á¤¿µ¹Ì(°í·ÁÀÇ´ë)

ÈÞ½Ä 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 10:30~10:50 Coffee Break ( )

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 10:50~11:15 First and Second Stage Labor Management (Guideline Update) ±è½Âö(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 11:15~11:40 Diagnosis and Management of Suspected Fetal Growth Restriction: an Evidence-based Approach (SMFM vs. ISUOG) À̽¹Ì(¼­¿ïÀÇ´ë)

Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 11:40~11:50 Discussion ( )

±âŸ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 11:50~12:00 °ø·ÎÆнûó ( )

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 12:00~12:20 Current Update on Vaginal Micronized Progesterone to Prevent Miscarriage ¼³ÇöÁÖ(°æÈñÀÇ´ë)

ÈÞ½Ä 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 12:20~13:10 Lunch ( )

Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:10~13:15 (Æ÷½ºÅÍ) ÀΰøÁö´É ±â¹Ý ºñħ½ÀÀû ÅÂ¾Æ ½É¹Úµ¿ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ °³¹ß À±¼öºó(¼­¿ïÀÇ´ë ¸¶ÃëÅëÁõÀÇÇаú)

Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:15~13:20 (Æ÷½ºÅÍ) Prevention of obstetric anal sphincter injuries with episiotomy : A retrospective cohort study À±ÁÖÈñ(¿¬¼¼ÀÇ´ë)

Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:20~13:25 (Æ÷½ºÅÍ) Development of a Nomogram for Birth Weight Prediction Using Prenatal Serum Screening Test and sFLT-1 Level ÀÌÀ¯¸®(¼º±Õ°üÀÇ´ë)

Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:25~13:30 (Æ÷½ºÅÍ) Comparison of Placenta Ultrastructure in high and low Exposure to Particulate Matter 2.5 during pregnancy ÀÌ°¡ÀÎ(ÀÌÈ­ÀÇ´ë)

Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:30~13:35 (Æ÷½ºÅÍ) The effects of DLK-1 and the IGF system on fetal growth restriction ÀÓµµÈ­(ÀÎÁ¦ÀÇ´ë)

Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:35~13:40 (Æ÷½ºÅÍ) Systematic Proteome Profiling of Maternal Plasma for Development of Predictive Biomarker of Preeclampsia ¾ç¼öÁö(Â÷ÀÇ°úÇдë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:40~13:50 (±¸¿¬) Comparative Analysis of Early Prediction Machine Learning Models for A1GDM and A2GDM: Differentiating Risk Factors ±è³ª¸®(Â÷ÀÇ°úÇдë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:50~14:00 (±¸¿¬) The Effect of Microplastics on the Human Pregnancy at the Maternal Fetal Interface ÇãÇý¿ø(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 14:00~14:10 (±¸¿¬) A multi-center, retrospective study comparing maternal and neonatal outcomes based on changes in HbA1c levels during the first and second trimester of pregnancy with overt diabetes. ±è¹ÌÁÖ(°æºÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 14:10~14:20 (±¸¿¬) Administration of Weissella confusa WIKIM51 modulates hepatic lipogenesis altered by maternal diet during pregnancy in a sex-dependent manner. ±è¼ö¹Î(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 14:20~14:30 (±¸¿¬) The adverse effect of nausea and vomiting during the first trimester might be different according to maternal body mass index ±è¼®¿µ(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 14:30~14:40 (±¸¿¬) Effectiveness of CD45 and CD56 cell surface negative markers for removal of maternal mononuclear cells in the enrichment of trophoblast from cervix sampling of pregnant women ÀåÀ±(Â÷ÀÇ°úÇдë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 14:40~15:00 (±¸¿¬) Postpartum Preeclampsia-Eclampsia: Defining and Management ±èÈ£¿¬(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 15:00~15:20 What¡¯s Known & What¡¯s New? (Focusing on Continuous Glucose Monitoring & Non-insulin Antidiabetic Treatment) È«¼öºó(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 15ÀÏ 15:20~15:40 Placenta Accreta Spectrum without Previa : Difficulties in Diagnosis ±ÇÇϾá(¿¬¼¼ÀÇ´ë)

±âŸ 06¿ù 15ÀÏ 15:40~15:50 Çмú»ó ½Ã»ó ( )

±âŸ 06¿ù 15ÀÏ 15:50~16:00 ÃÑȸ ( )

±âŸ 06¿ù 15ÀÏ 16:00~16:05 Æóȸ»ç ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѸðüžÆÀÇÇÐȸ Á¦30Â÷ Çмú´ëȸ : 2024-06-15""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽɺÎÀüÇÐȸ 2024 ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-15
´ÙÀ½±Û È£³²½½°üÀý¿¬±¸È¸ Á¦76Â÷ Áý´ãȸ : 2024-06-15
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21062 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(4ÀÏÂ÷) : 2024-07-04 0 57 2024-06-18
21061 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ÀçÅÃÀÇ·á ȯÀÚ Áø·áÀÇ ½ÇÁ¦ : 2024-07-04 0 25 2024-06-18
21060 ¿ï»ê ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ¿ï»êÁöȸ ¿¬¼ö±³À°(¿ù°æÅë, µ¥³ë¼ö¹ä Áß´Ü ÈÄ ¹Ýµ¿°ñÀýÀÇ ¿¹¹æ) : 2024-07-04 0 46 2024-06-18
21059 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(3ÀÏÂ÷) : 2024-07-03 0 11 2024-06-18
21058 °æ±â 2024³â ÆòÅýÃÀÇ»çȸ ÇÏ°èÇмú´ëȸ : 2024-07-02 0 54 2024-06-18
21057 ¼­¿ï ¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(2ÀÏÂ÷) : 2024-07-02 0 31 2024-06-18
21056 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 19 2024-06-18
21055 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(1ÀÏÂ÷) : 2024-07-01 0 17 2024-06-18
21054 ÃæºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Understanding Current Community Mental Health and Emotional Disorders in ASD : 2024-07-01 0 43 2024-06-18
21053 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 51 2024-06-18
21052 °æ±â ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ - Á¦2ȸ CHAMS °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 45 2024-06-18
21051 ¼­¿ï 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ ¼­¿ïÁöȸ Çϰ迬¼ö°­Á : 2024-06-30 0 63 2024-06-18
21050 ºÎ»ê 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2024-06-30 0 28 2024-06-18
21049 ¼­¿ï Á¦26Â÷ ´ëÇѾƵ¿º´¿øÇùȸ Ãá°èÇмú´ëȸ : 2024-06-30 0 25 2024-06-18
21048 Ãæ³² 2024 ÀÌ°úÇÐ ¿¬±¸¼¼¹Ì³ª : 2024-06-29 0 20 2024-06-18
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷